What is GKOS (GKOS) stock price today?

GKOS (GKOS) is currently trading at $176.70, down 1.59% today.

What is GKOS P/E ratio?

GKOS's P/E ratio is -42.65. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GKOS return on equity (ROE)?

GKOS's return on equity (ROE) is -28.66%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is GKOS's market cap?

GKOS has a market capitalization of $10.42B.

NYSE · Medical - Devices

GKOS (GKOS) Stock

$176.70 -1.59% NYSE: GKOS Healthcare

Valuation

Metric	Value
Price	$176.70
Market Cap	$10.42B
P/E Ratio	-42.65
P/B Ratio	12.53
P/S Ratio	14.90
EPS (TTM)	$-3.28
52-Week High	$191.20
52-Week Low	$73.16
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-28.66%
ROA	-21.05%
ROCE	-13.26%
Gross Margin	-17.16%
Operating Margin	-17.16%
Net Margin	-34.34%
Debt/Equity	0.15
Current Ratio	4.70

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$294.0M	$283.0M	$315.0M	$383.0M	$507.0M
Operating Profit	$-33.0M	$-82.0M	$-129.0M	$-122.0M	$-87.0M
Net Profit	$-50.0M	$-99.0M	$-135.0M	$-146.0M	$-188.0M
EPS	$-1.07	$-2.09	$-2.78	$-2.77	$-3.28
Op Margin	-11.2%	-29.1%	-40.9%	-31.9%	-17.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.1B	$1.1B	$940.0M	$975.0M	$893.0M
Total Liabilities	$542.0M	$544.0M	$479.0M	$208.0M	$237.0M
Cash	$101.0M	$120.0M	$93.0M	$170.0M	$91.0M
Borrowings	$383.0M	$383.0M	$384.0M	$106.0M	$140.0M

Latest News

Truist Adjusts Price Target on Glaukos to $180 From $160, Maintains Buy Rating MT Newswires · Jul 16, 2026 GKOS: Raising target price to $160.00 Argus Research · Jul 15, 2026 Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? Motley Fool · Jul 14, 2026 Glaukos Insider Sold Shares Worth $1,550,000, According to a Recent SEC Filing MT Newswires · Jul 14, 2026 Glaukos Insider Sold Shares Worth $1,500,000, According to a Recent SEC Filing MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$25.0M	$-33.0M	$-58.0M	$-61.0M	$-46.0M
Investing Cash Flow	$-106.0M	$15.0M	$-6.0M	$42.0M	$-85.0M
Financing Cash Flow	$9.0M	$-2.0M	$-3.0M	$-7.0M	$12.0M
Net Cash Flow	$4.0M	$19.0M	$-26.0M	$76.0M	$-111.0M
Free Cash Flow	$-23.0M	$-63.0M	$-78.0M	$-68.0M	$-54.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-0.22%
Quick Ratio	4.73
Interest Coverage	-17.40
Return 1Y	86.28%
Return 3Y	137.89%
Return 5Y	217.79%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACLXArcellx, Inc.	$115.07	+0.02%	-28.27	$6.73B	0.00%
ALKS	$47.20	+0.45%	25.87	$7.92B	0.00%
ARWR	$82.74	+0.42%	-7397.00	$11.65B	0.00%
BLCO	$17.88	+2.29%	13.97	$6.39B	0.00%
BRKR	$56.03	-3.41%	23.24	$8.53B	0.35%

About GKOS

GKOS is led by CEO Thomas William Burns, employs 1,094 people, headquartered in Aliso Viejo, US, publicly traded since 2015.

GKOS stock trades at $176.70 with a market capitalization of $10.42B. The stock is valued at a price-to-earnings (P/E) ratio of -42.65, price-to-book of 12.53, price-to-sales of 14.90. Over the past 52 weeks the stock has ranged between $73.16 and $191.20, and currently trades 7.6% below its 52-week high.

On profitability, GKOS generates a return on equity (ROE) of -28.66%, return on capital employed of -13.26%, an operating margin of -17.16%, a net profit margin of -34.34%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides